Nigel Harford

Title: The Innovations of Nigel Harford

Introduction

Nigel Harford is a notable inventor based in Overijse, Belgium. He has made significant contributions to the field of biotechnology, particularly in the development of vaccines and immunogens. With a total of two patents to his name, his work has the potential to impact public health positively.

Latest Patents

Harford's latest patents include innovative methods for creating composite particles that present multiple antigenic determinants related to hepatitis B surface antigens. His invention involves a modified hepatitis B surface antigen L protein, which can be utilized alone or incorporated into composite particles. This advancement aims to improve hepatitis B vaccines, especially through expression in yeasts such as S. cerevisiae and Hansenula polymorpha. Additionally, he has developed processes for producing DNA sequences and recombinant DNA molecules that code for subunits of cholera toxin, enhancing the potential for vaccine development.

Career Highlights

Throughout his career, Nigel Harford has worked with prominent companies in the biotechnology sector, including SmithKline Beecham and SmithKline Biologicals, S.A. His experience in these organizations has allowed him to refine his expertise in vaccine development and immunology.

Collaborations

Harford has collaborated with notable colleagues in his field, including Michel De Wilde and Martin Comberbach. These partnerships have contributed to the advancement of his research and innovations.

Conclusion

Nigel Harford's contributions to biotechnology and vaccine development demonstrate his commitment to improving public health through innovative solutions. His patents reflect a deep understanding of immunology and a dedication to advancing medical science.